Clinical Trial Update: Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Ruxolitinib With Artemether-lumefantrine [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of ruxolitinib with artemether-lumefantrine for malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Artemether-lumefantrine (artemether and lumefantrine)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2021-07-09